Back to Search Start Over

99 CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)-DEFINED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS).

Authors :
Garcia-Manero, G.
Savona, M.R.
Gore, S.D.
Cogle, C.R.
Conkling, P.
Hetzer, J.
Dong, Q.
Ukrainskyj, S.M.
Skikne, B.S.
Source :
Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS50-S51. 1p.
Publication Year :
2015

Details

Language :
English
ISSN :
01452126
Volume :
39
Database :
Academic Search Index
Journal :
Leukemia Research
Publication Type :
Academic Journal
Accession number :
102317965
Full Text :
https://doi.org/10.1016/S0145-2126(15)30100-4